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Key points
 Age significantly modifies the relationship between aortic pulse wave velocity and telomere
length.
 The differential relationships observed between aortic pulse wave velocity and telomere length
in younger and older individuals suggest that the links between cellular and vascular ageing
reflect a complex interaction between genetic and environmental factors acting over the
life-course.
Abstract Ageing is associated withmarked large artery stiffening. Telomere shortening, a marker
of cellular ageing, is linked with arterial stiffening. However, the results of existing studies are
inconsistent, possibly because of the confounding influence of variable exposure to cardiovascular
risk factors. Therefore, we investigated the relationship between telomere length (TL) and aortic
stiffness in well-characterized, younger and older healthy adults, who were pre-selected on the
basis of having either low or high aortic pulse wave velocity (aPWV), a robust measure of aortic
stiffness. Demographic, haemodynamic and biochemical data were drawn from participants in
the Anglo-Cardiff Collaborative Trial. Two age groups with an equal sex ratio were examined:
those aged <30 years (younger) or >50 years (older). Separately for each age group and sex,
DNA samples representing the highest (n = 125) and lowest (n = 125) extremes of aPWV
(adjusted for blood pressure) were selected for analysis of leukocyte TL. Ultimately, this yielded
complete phenotypic data on 904 individuals. In younger subjects, TL was significantly shorter
in those with high aPWV vs. those with low aPWV (P = 0.017). By contrast, in older subjects,
TL was significantly longer in those with high aPWV (P = 0.001). Age significantly modified the
relationship between aPWV and TL (P < 0.001). Differential relationships are observed between
aPWV and TL, with an inverse association in younger individuals and a positive association in
older individuals. The links between cellular and vascular ageing reflect a complex interaction
between genetic and environmental factors acting over the life-course.
(Resubmitted 25 October 2016; accepted after revision 28 November 2016; first published online 12 December 2016)
Corresponding author B. J. McDonnell: Cardiff School of Health Sciences, Cardiff Metropolitan University, Cardiff
CF5 2YB, UK. Email: bmcdonnell@cardiffmet.ac.uk
Abbreviations aPWV, aortic pulse wave velocity; BMI, body mass index; CRP, C-reactive protein; CV, cardiovascular;
HDL, high-density lipoprotein; MAP, mean arterial pressure; T/S, telomere/standard; TL, telomere length.
∗These authors contributed equally to this work.
2016 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society DOI: 10.1113/JP273689
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution
and reproduction in any medium, provided the original work is properly cited.
2 B. J. McDonnell and others J Physiol 000.00
Introduction
With ageing, large arteries stiffen as a consequence
of elastin degradation and/or vascular remodelling
(London, 2001; Yasmin et al. 2005), which manifests
as an increase in aortic pulse wave velocity (aPWV)
throughout life (McEniery et al. 2005). Therefore, aPWV
has become a widely accepted measure of vascular age.
Traditional cardiovascular (CV) risk factors (e.g. total
cholesterol, glucose, physical inactivity) and inflammation
are associated with increased aPWV (Mora et al. 2007;
McEniery et al. 2008; McDonnell et al. 2013) and
aPWV is now recognized as an important, independent
determinant of CV disease progression (Safar et al. 2003)
and events (Ben-Shlomo et al. 2014). However, although
the severity and life-course of exposure to CV risk factors
increase over time, these factors do not account for all of
the risk associated with vascular ageing, suggesting that
other mechanisms must be involved.
In recent years, shortening of telomeric DNA has
been linked with biological ageing (Samani & van
der Harst, 2008; Huzen et al. 2010). Telomeres are
specialized DNA protein complexes located at both ends
of each chromosome and function as chromosomal caps
preventing genetic instability and cellular senescence
(Karlseder et al. 2002; Artandi, 2006). With increasing
age and number of cell divisions, progressive shortening
of telomere length (TL) leads to a point of cellular
senescence, suggesting that TL provides a measure of
cellular age (Blasco, 2005). Two recent meta-analyses have
demonstrated that telomere shortening is related to CV
(Haycock et al. 2014) and metabolic outcomes (D’Mello
et al. 2015), although there was significant heterogeneity
in observations within these studies. Interestingly, pre-
vious studies have also reported significant cross-sectional
associations between TL andmeasures of vascular stiffness
(Benetos et al. 2001; Nawrot et al. 2010; Wang et al.
2011) and a recent longitudinal study illustrated that a
faster rate of telomere shortening was associated with
increased carotid intima-media thickness, independent
of traditional CV risk factors (Masi et al. 2014), leading
to the hypothesis that telomere shortening provides a
cellular and genetic link to vascular ageing. However,
observational studies conducted mostly in middle-aged
and older adults have shown weak or no relationship
between TL and chronological age, vascular stiffness or
CV disease (Tentolouris et al. 2007; De Meyer et al. 2012;
Morgan et al. 2014).
In the present study, we explored the relationship
between TL and aortic stiffness in two distinct groups
of healthy individuals; those aged less than 30 years and
those over 50 years, who were pre-selected on the basis
of having aPWV in the lower or upper extremes for their
age group and sex. We hypothesized that higher aPWV is
associated with shorter TL in healthy individuals.
Methods
Study population
Data on men and women, where complete information
concerning demographic, haemodynamic and bio-
chemical characteristics were available, were drawn from
the Anglo-Cardiff Collaborative Trial (McEniery et al.
2005), which consists of approximately 4500 individuals
with detailed phenotypic data. Two age groups were
examined: those aged <30 years (younger) or >50 years
(older). Because aPWV is closely related to the mean
arterial pressure (MAP; higher MAP = higher aPWV),
aPWV was adjusted for MAP using linear univariate
regression models, separately for each age group and sex,
after determining that analyses based on linear models
were the most appropriate for each group. This approach
ensured that we examined associations between TL and
intrinsic aortic stiffness, rather than simply selecting
samples for TL analysis based on a proxy for blood
pressure. Samples were then selected on the basis of the
MAP-adjusted aPWV of an individual being located in
either ‘extreme’ of the aPWV distribution (i.e. upper or
lower 15%), which equated to the highest (n = 125) and
lowest (n = 125) aPWV values for each age-group and
sex. This yielded samples from 1000 healthy individuals,
who were free from CV disease and medication, and who
had undertaken a detailed lifestyle and medical history
questionnaire (Fig. 1). The study complied with the
Declaration of Helsinki and ethical approval was obtained
from the Local Research Ethics Committees, with written
informed consent being provided by all participants.
Protocol
Height and weight were assessed and a medical history
questionnaire, including details of medication was
completed. Following 15 min of supine rest, brachial
blood pressure and carotid and femoral artery pressure
waveforms were recorded, and aPWV determined. Blood
samples (20 mL) were then drawn from the antecubital
fossa. Serum, plasma and buffy coat samples were then
obtained and stored at −80 °C for subsequent analyses.
Cholesterol, triglycerides, glucose and C-reactive protein
(CRP) were determined using a standard methodology in
an accredited laboratory.
Haemodynamic measurements
Brachial bloodpressurewasmeasuredwith the participant
resting supine, using a validated semi-automated
oscillometric device (HEM-705CP; Omron Corporation,
Kyoto, Japan), in accordance with the British Hyper-
tension Society guidelines (O’Brien et al. 1996). All
measurements were taken in duplicate and mean values
wereused in the subsequent analyses. aPWVwasmeasured
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using the SphygmoCor system (Atcor Medical, Sydney,
Australia) by sequentially recording ECG-gated carotid
and femoral artery waveforms, as previously described
in detail (Wilkinson et al. 1998). Path length for the
determination of aPWV was measured, using a tape
measure, as the surface distance between the supra-sternal
notch and femoral site minus the distance between the
supra-sternal notch and carotid site.
DNA extraction, quantification and assessment of TL
DNA was extracted from the buffy coats using a
commercially available GeneCatcher kit (Invitrogen,
Paisley, UK) and then quantified and checked for
purity using a Nanodrop ND-1000 spectrophotometer
(Labtech, Uckfield, UK). DNA quality was assessed by the
absorbance ratio at 260 and 280 nm, and only samples
with a ratio between 1.8 and 1.9 were included in the
study. In addition, the integrity of the DNA samples was
confirmed by gel electrophoresis in 50 randomly selected
samples. Leukocyte relative mean TL was measured as
the telomere/standard (T/S) ratio in triplicate by a mono-
chromemultiplex quantitative PCR assay, using a Bio-Rad
CFX96TM RT-PCR detection system (Bio-Rad, Hemel
Hempstead, UK) as described previously (Steptoe et al.
2011). TL is expressed as the ratio of the telomeric DNA
signal to the signal of the single copy geneβ-globin, used as
an internal standard (T/S ratio) (Cawthon, 2009). There
was very little variability between the triplicate readings
(<2%) in samples from the two study groups, confirming
the good reliability of the quantitative PCR assays.
Statistical analysis
All data were analysed using SPSS, version 20.0
(IBM Corp., Armonk, NY, USA). Two-way ANOVA
(age × aPWV) was used to investigate the relationship
between aPWV and haemodynamic and biochemical
variables, including the T/S ratio. A test for inter-
action was used to determine whether age modified any
of these associations, with planned contrasts used to
examine differences between aPWV groups for younger
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Figure 1. Group stratification and classification.
[Colour figure can be viewed at wileyonlinelibrary.com]
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and older individuals, respectively. Amodified Bonferroni
correctionwas applied to adjust formultiple comparisons.
Pearson correlation coefficients were used to determine
bivariate correlations between variables. Finally, within
each age group, multiple regression analyses based on
the enter method were performed to determine those
parameters remaining independently associated with
aPWV, after including variables traditionally known to
confoundmeasurements of aPWV (McEniery et al. 2010).
Linear models were chosen after establishing that these
provided similar associations with age compared to
non-linear approaches. Log-transformed T/S ratio values
were used for all analyses because the T/S ratio was
non-normally distributed. Unless otherwise stated, the
results are expressed as the mean ± SD. P < 0.05 was
considered statistically significant.
Results
In total, 96 samples were excluded from the analysis
because of poor quality or insufficient DNA to enable
accurate detection of TL, yielding 422 young participants
(212 with low aPWV and 210 with high aPWV) and 482
older participants (242 with low aPWV and 240 with high
aPWV) in whom complete data were available (Fig. 1).
Anthropometric characteristics
Anthropometric characteristics are presented inTable 1. In
the younger participants, onlyweight andbodymass index
(BMI) were significantly higher in those with high vs. low
aPWV(P=0.013andP=0.016, respectively).However, in
older participants, weight, BMI, smoking status and pack
years were all significantly higher in thosewith high vs. low
aPWV (P < 0.001, P = 0.001, P = 0.026 and P = 0.002,
respectively). Age significantly modified the relationship
between aPWV and smoking pack years (P = 0.017).
Haemodynamic indices
Haemodynamic indices are presented in Fig. 2 andTable 1.
No significant differences were observed between younger
participants with low vs. high aPWV. By contrast, in
older participants, brachial diastolic blood pressure was
significantly lower and pulse pressure and heart rate were
significantly higher in those with high aPWV (P = 0.002,
P = 0.004 and P < 0.001, respectively). Age significantly
modified the relationship between aPWV and brachial
pulse pressure and heart rate (P = 0.010 and 0.001,
respectively).
Biochemical indices
Total andhigh-density lipoprotein (HDL) cholesterolwere
both significantly higher in younger participantswith high
aPWV vs. those with low aPWV (P= 0.007 and P= 0.018,
respectively). By contrast, HDL was significantly lower
(P = 0.002) and triglycerides and CRP significantly
higher (P < 0.001 and P = 0.001, respectively) in older
participants with high aPWV vs. those with low aPWV.
Age significantlymodified the relationship between aPWV
and total cholesterol, HDL cholesterol and triglycerides
(P = 0.011, P < 0.001 and P = 0.001, respectively).
Telomere length
As hypothesized, the T/S ratio was significantly lower
in young participants with high aPWV vs. those with
low aPWV (P = 0.017). By contrast, the T/S ratio
was significantly higher in older participants with high
aPWV vs. those with low aPWV (P < 0.001). Age
significantlymodified the relationship between aPWVand
T/S ratio (P < 0.001). Treating the data as continuous
variables, aPWV was inversely correlated with T/S ratio
(r = −0.12, P = 0.013) in younger participants but
positively correlated with T/S ratio in older participants
(r= 0.20, P< 0.001). Inmultiple regression analyses, after
entering traditional confounding factors, the T/S ratio
remained independently associated with aPWV in both
younger and older participants. However, the association
remained inverse in younger participants (Table 2) but
positive in older participants (Table 3).
Discussion
The present study is the first to illustrate that age
modifies the association between TL and aPWV in
healthy individuals, with an inverse association present in
younger individuals and a positive association present
in older individuals. These data suggest that the links
between cellular and vascular ageing reflect a complex
interaction between genetic and environmental factors
acting over the life-course.
Our data are in agreement with the majority of
published studies showing that shorter TL is associated
with increased chronological age (Blasco, 2005). TL is
also considered to be significantly affected by genetics,
(Brouilette et al. 2008; Samani & van der Harst, 2008),
together with psychosocial and environmental factors
such as hostility (Brydon et al. 2012), educational
attainment (Steptoe et al. 2011), sleepduration (Jackowska
et al. 2011) and oxidative stress (Kiecolt-Glaser et al.
2013; Tarry-Adkins & Ozanne, 2014). Moreover, TL has
been linked with both metabolic and CV outcomes
in recent meta-analyses (Haycock et al. 2014; D’Mello
et al. 2015), albeit with significant heterogeneity between
observations within these studies. Interestingly, recent
data also suggest that both genetic and environmental
factors affect large artery stiffness (McEniery et al. 2008;
Yasmin & O’Shaughnessy, 2008; Mitchell et al. 2012;
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Table 1. Comparisons and interactions between demographic, haemodynamic and biochemical variables for low and high aPWV
groups in younger and older individuals
Younger Older
Low High Low High
Overall
ANOVA Interaction
Parameter aPWV aPWV aPWV aPWV P value P value
n 212 210 242 240
Age (years) 20 ± 4 20 ± 2 68 ± 7 67 ± 7 <0.001 0.060
Sex (% male) 49 49 50 50 0.983 0.869
Height (m) 1.7 ± 0.1 1.7 ± 0.1 1.7 ± 0.1 1.7 ± 0.1 <0.001 0.904
Weight (kg) 67.3 ± 13.6 70.5 ± 13.4∗ 72.1 ± 14.1 76.7 ± 14.5∗∗∗ <0.001 0.436
BMI (kg m–2) 22.7 ± 3.4 23.5 ± 3.5∗ 25.9 ± 4.2 27.1 ± 4.5∗∗ <0.001 0.336
Smokers (%) 10.1 ± 30.1 15.0 ± 35.8 8.6 ± 26.5 13.7 ± 34.5∗ <0.001 0.776
Smokers (pack years) 1.0 ± 3.1 1.4 ± 3.3 4.1 ± 8.0 6.7 ± 10.2∗∗ <0.001 0.017
Brachial SBP (mmHg) 116 ± 13 115 ± 13 139 ± 17 140 ± 20 <0.001 0.324
Brachial DBP (mmHg) 68 ± 8 68 ± 8 81 ± 9 78 ± 9∗∗ <0.001 0.051
Brachial PP (mmHg) 49 ± 12 48 ± 11 58 ± 13 62 ± 15∗∗ <0.001 0.010
Brachial MAP (mmHg) 82 ± 9 81 ± 9 102 ± 11 100 ± 13 <0.001 0.717
HR (beats min–1) 67 ± 12 68 ± 12∗ 64 ± 9 70 ± 10∗∗∗ <0.001 0.001
aPWV (m s–1) 4.6 ± 0.4 6.8 ± 0.8∗∗∗ 7.3 ± 1.2 12.4 ± 2.2∗∗∗ <0.001 <0.001
Adj aPWV (m s–1) 4.6 ± 0.4 6.9 ± 0.5∗∗∗ 6.7 ± 0.8 12.1 ± 1.6∗∗∗ <0.001 <0.001
Total cholesterol (mmol l–1) 3.94 ± 0.83 4.16 ± 0.88∗∗ 5.65 ± 1.11 5.54 ± 1.08 <0.001 0.011
HDL (mmol l–1) 1.40 ± 0.40 1.49 ± 0.40∗ 1.61 ± 0.39 1.49 ± 0.43∗∗ <0.001 <0.001
LDL (mmol l–1) 2.16 ± 0.70 2.23 ± 0.76 3.49 ± 0.92 3.35 ± 0.94 <0.001 0.059
Triglycerides (mmol l–1) 0.96 ± 0.67 1.10 ± 0.07 1.29 ± 0.64 1.49 ± 0.43∗∗∗ <0.001 0.001
Glucose (mmol l–1) 4.81 ± 0.97 4.78 ± 1.68 5.09 ± 2.86 5.17 ± 1.38 0.067 0.656
CRP (mg l–1) 2.25 ± 3.45 2.27 ± 2.83 2.67 ± 3.91 4.17 ± 6.05∗∗ 0.001 0.169
Log-transformed T/S ratio 0.100 ± 0.118 0.076 ± 0.086∗ 0.012 ± 0.111 0.052 ± 0.099∗∗∗ <0.001 <0.001
SBP, systolic blood pressure; DBP, diastolic blood pressure; PP, pulse pressure; Adj aPWV, aortic pulse wave velocity adjusted for mean
arterial pressure; LDL, low-density lipoprotein. Overall ANOVA represents the results of two-way ANOVA. Interaction represents the
age × aPWV interaction term. ∗P < 0.05, ∗∗P < 0.01 and ∗∗∗P < 0.001 vs. the Low aPWV group.
McDonnell et al. 2013) and a recent large meta-analysis
demonstrated that aPWV independently predicts stroke
and CV outcomes (Ben-Shlomo et al. 2014). However, the
links between cellular and vascular ageing are not well
understood, and merit further investigation.
A recent longitudinal study illustrated that a faster
rate of telomere shortening is associated with increased
carotid intima-media thickness (Masi et al. 2014)
in middle-aged individuals, indicating that accelerated
cellular ageing is associated with early atherosclerosis.
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Figure 2. Difference in T/S ratio between the Low and High aPWV groups
A, younger individuals. B, older individuals. [Colour figure can be viewed at wileyonlinelibrary.com]
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Table 2. Multiple regression analysis illustrating the parameters associated with aPWV in younger individuals
Dependent variable: aPWV
Unstandardized
β SE
Standardized
coefficients (β) t P value
Age 0.073 0.240 0.147 2.997 0.003
Sex −0.221 0.121 −0.089 −1.822 0.069
Mean arterial pressure 0.019 0.008 0.135 2.557 0.011
Heart rate 0.013 0.005 0.126 2.472 0.014
BMI 0.035 0.019 0.094 1.895 0.059
Smoking status 0.194 0.106 0.087 1.822 0.069
T/S ratio −1.375 0.581 −0.113 −2.368 0.018
Table 3. Multiple regression analysis illustrating the parameters associated with aPWV in older individuals
Dependent variable: aPWV
Unstandardized
β SE
Standardized
coefficients (β) t P value
Age 0.088 0.019 0.199 4.702 <0.001
Sex −0.287 0.276 −0.046 −1.217 0.299
Mean arterial pressure 0.048 0.011 0.181 4.158 <0.001
Heart rate 0.087 0.013 0.284 6.557 <0.001
BMI 0.091 0.031 0.128 2.912 0.004
Smoking status 0.161 0.148 0.048 1.090 0.276
T/S ratio 4.709 1.289 0.160 3.653 <0.001
Furthermore, cross-sectional studies have shown that
a shorter TL is associated with measures of vascular
stiffness, including increased aPWV and reduced carotid
distensibility (Benetos et al. 2001; Nawrot et al. 2010;
Wang et al. 2011). However, other cross-sectional studies
have reported no association between TL and arterial
stiffness in females (Benetos et al. 2001) and in diabetics
(Tentolouris et al. 2007). Unfortunately, all of these
studies contained relatively few subjects, with significant
associations between TL and stiffness being reported in
males only.Moreover, the studies included predominantly
older adults, inwhom the degree of life-course exposure to
cardiovascular risk factors probably differed significantly
between individuals.
In the present study, we examined distinct groups of
younger and older individuals, selected from the extremes
of the aPWV distribution. This approach allowed us
to explore the association between cellular and vascular
ageing with sufficient power. However, we attempted to
minimize the confounding influence of blood pressure on
aPWV by selecting samples for analysis of TL based on
aPWV values that had been adjusted for blood pressure.
The significant, inverse association between aPWV and
TL observed in younger individuals suggests that cellular
and vascular ageing may be linked in these individuals,
with TL remaining independently associated with aPWV
inmultiple regression analyses. Aortic stiffness is relatively
homogeneous in younger individuals, with a smaller
spread of values and a SD from themean of approximately
half that seen in individuals aged >50 years (McEniery
et al. 2005). This homogeneity may reflect the limited
exposure to cardiovascular and other risk factors in
younger, compared to older, individuals. Nevertheless,
meaningful differences in aPWV can still be observed
in younger subjects, especially when extremes of the
distribution are considered, as in thepresent study. Indeed,
based on our data, a difference of 0.09 in T/S ratio was
equivalent to a difference in vascular age of approximately
20 years, according to the spread of aPWV values for the
whole group.
By contrast, although aortic stiffness is greater in
older individuals, it is much more heterogeneous, which
most probably reflects variations between individuals
in life-course environmental exposures, and their inter-
action with genetics and/or early life factors. As such, the
positive association between TL and aPWV observed in
older individuals in the present study argues against any
direct link between cellular and vascular ageing in these
individuals. Instead, it may be that associations between
cellular and vascular ageing in certain individuals are
influenced by exposure to common (or different) risk
factors, or that different processes drivedifferent biological
markers of ageing in older individuals. Alternatively,
recent data suggest that individuals with longer TL at
younger ages tend to show a greater rate of TL shortening
with age (Muezzinler et al. 2013; Weischer et al. 2014),
which may account for some of our findings. Inter-
estingly inter-individual differences in TL are assumed
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to be established early in life (Daniali et al. 2013) and may
partly determine individual trajectories of TL shortening
over the life-course.However, our data in older individuals
are probably influenced by a healthy survivor effect. That
is, individuals with high aPWV and short TL may have
been selected out of the analysis because of the pre-
sence or a history of CV disease and events. Nevertheless,
the current data in older individuals may explain, in part,
the heterogeneity betweenTLandCVoutcomes (Weischer
et al. 2014;D’Mello et al. 2015) and cerebrovascular disease
(Haycock et al. 2014) reported previously and raise the
questionofwhetherTL alone shouldbeused as amarker of
CV risk in older individuals becausemany factors decrease
or even increase TL, independently of age.
Clearly any observed association betweenTL and aPWV
in our data relies on the assumption that leukocyte
TL reflects the TL of aortic tissue, which may not
necessarily be the case. Indeed, a previous study based
on post-mortem tissue (Takubo et al. 2002) found no
evidence of a cross-sectional association between age and
TL in myocardium or cerebral cortex (probably reflecting
thepost-mitotic nature of these tissues), despite significant
correlations in other tissues. Two comparatively small
studies of aortic tissue biopsies have reported contra-
dictory findings. In 51 individuals aged between 1 month
and 80 years, there was a significant age-associated
reduction in aortic TL (Okuda et al. 2000). However, in a
further study, TL of leukocytes and aortic tissue biopsies
were significantly correlated, both in patients undergoing
elective abdominal aortic aneurysm repair or controls
without aortic disease at the time of cadaveric donation
(Wilson et al. 2008). However, in this relatively small study
population, there was no correlation between either aortic
or leukocyte TL and age, although the age-range of the
study population was narrow.
The present study has some limitations. As a result
of the cross-sectional design, it was not possible to
examine causal relationships or assess inter-individual
differences in the rate of TL shortening. Moreover,
although we consider that our strategy of comparing TL
between extremes of aPWV provided a robust approach
for evaluating the relationship between cellular and
vascular ageing, the use of extreme samples may increase
the potential for sampling bias and could overestimate
the strength of associations between variables (Salkind,
2010). Furthermore, in adjusting aPWV for differences
in blood pressure, we cannot exclude the possibility
that the pressure-dependence of aPWV differs between
younger andolder individuals. Becauseof the retrospective
nature of the study, it was not possible to measure
telomerase activity, which may have been increased to
protect the telomeres from oxidative stress, degradation
and shortening, as has been suggested in other studies
(Brydon et al. 2012; Kiecolt-Glaser et al. 2013). Finally,
any observed association between TL and aPWV in our
data relies upon the assumption that leukocyte TL reflects
TLwithin the aorticwall, whichwewere unable to confirm
in the present study.
In conclusion, we have shown, for the first time, an
inverse association between TL and aPWV in younger
individuals but a positive association in older individuals.
Therefore, our data illustrate that age significantly
modifies the relationshipbetweenaPWVandTL inhealthy
individuals. These data suggest that links between cellular
and vascular ageing reflect a complex interaction between
genetic and environmental factors acting over the whole
life-course and that future studies should take account of
this possibility. Future longitudinal studies are therefore
required to better understand these factors throughout the
life-course of biological ageing and their implications in
understanding CV risk.
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